🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Delayed Release Vegetarian Capsule(s) Serving Size
60 Servings
Other Combinations Product Type
40% Evidence Coverage

Supplement Facts — Evidence Check

5 mg (294% DV)
📊 3.8× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 5mg UL 100mg
45 mg (11% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 45mg
Citric Acid
350 mg
Phytin
200 mg
Banana
200 mg

Other Ingredients

Cellulose Magnesium Stearate Silicon Dioxide Gellan Gum Titanium Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (43% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Sugar Free

Product Information

📋 Directions for Use

Directions: Take two (2) capsules twice daily (and and pm) preferably with meals. For best results, it is recommended to consume at least six 8-ounce glasses of water daily with lemon juice, decrease caffeine intake, eliminate colas, decrease oxalate-rich foods such as spinach, strawberries, nuts, and tea, decrease sodium, sugar, and red meat consumption and increase fiber intake.

⚠️ Warnings & Precautions

Important: Tamper resistant outer seal around cap and pressure seal under cap. Do not use if either seal is broken or missing.

Keep out of reach of children.

Caution: If you are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

🧪 Formulation Notes

Kidney C.O.P. was specifically formulated to help inhibit the rate of growth and formation of calcium oxalate crystals. This new, patented and revolutionary formula contains select ingredients sourced from around the world that are demonstrated to affect calcium oxalate crystal formation. Optimized and patented five ingredient formula Encapsulated in USA with select FDA G.R.A.S. ingredients

Free of any preservatives, artificial colors, flavors, sweeteners, sugars, soy, gluten, wheat, yeast, fish and sodium.

In vitro tests show that patented formula inhibits rate of calcium oxalate crystal growth by 99%.

Four of five ingredients are FDA G.R.A.S., the other is natural banana stem (Musa paradisiaca)

Patented formula 99% inhibition of calcium oxylate crystals Ingredients clinically shown to inhibit calcium oxalate crystals Supports proper kidney function and health

Additional Information

Manufactured in a FDA registered cGMP facility

Manufactured at an FDA registered facility

GRAS Generally Recognized As Safe

Encapsulated in USA

GMP quality Good Manufacturing Practice certification

Store at room temperature, tightly closed.

Calcium Oxalate Protector

30 day supply

Product Details

UPC / SKU X001G8BF9V
DSLD Entry Date 2019-10-23
Product Type Other Combinations
Form Capsule
DSLD ID 207062
Data Updated 2026-04-11

Research Evidence

153 Research Sources
55 Avg Quality Score
71 Systematic Review
51 Meta Analysis
19 Rct
6 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ (Clinical research ed.) 2013
A Homocysteine lowering interventions for preventing cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2009
A Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies
Meta Analysis Critical reviews in food science and nutrition 2019
A Exploring the causal associations of micronutrients on urate levels and the risk of gout: A Mendelian randomization study
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2024
A Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
B Prophylactic drug management for febrile seizures in children
Meta Analysis The Cochrane database of systematic reviews 2021
B Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review
Systematic Review JAMA 2016
B The potential role of nutritional components in improving brain function among patients with Alzheimers disease: a meta-analysis of RCT studies
Meta Analysis Neurosciences (Riyadh, Saudi Arabia) 2020
B Pyridoxine (vitamin B6) supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2006
B Effect of ginger in the treatment of nausea and vomiting compared with vitamin B6 and placebo during pregnancy: a meta-analysis
Meta Analysis The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2022
View all evidence for Vitamin B6 →

Compare Similar Products

View all Vitamin B6 products →